cabotegravir
Also known as GSK744
Cabotegravir, sold under the brand name Vocabria among others, is an antiretroviral medication used for the treatment and prevention of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva.
Key facts
- Drug.image
- Cabotegravir (GSK744).svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Cabotegravir ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Vocabria, Apretude
- Drug.MedlinePlus
- a621010
- Drug.DailyMedID
- Cabotegravir
- Drug.pregnancy_AU
- B1
- Drug.routes_of_administration
- By mouth, intramuscular
- Drug.ATC_prefix
- J05
- Drug.ATC_suffix
- AJ04
- Drug.legal_AU
- S4
- Drug.legal_CA
~8 min read
Article
16 sectionsContents
- Medical uses
- Contraindications and interactions
- Adverse effects
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Pharmacogenomics
- Chemistry
- Formulation
- History
- Society and culture
- Legal status
- Names
- Research
- Pre-exposure prophylaxis
- References
Cabotegravir, sold under the brand name Vocabria among others, is an antiretroviral medication used for the treatment and prevention of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva.
It is an integrase inhibitor with a carbamoyl pyridone structure similar to that of dolutegravir.
Connections
Categories
4-PyridonesAntiretroviral drugsCarboxamidesChemical articles with multiple CAS registry numbersChemical articles with multiple ChEBIsChemical articles with multiple PubChem CIDsChemicals using indexlabelsDrugs developed by GSK plcDrugs with non-standard legal statusECHA InfoCard ID from WikidataFluoroarenesHeterocyclic compounds with 3 rings